Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (421-430 of 1,726) with videos related to

Pageof 173
Sort By:
Journal of Pharmaceutical Sciences|May 1, 1970
Controlled drug release through polymeric filmsA L Fites, G S Banker, V F Smolen
Rheumatology (Oxford, England)|May 26, 1999
Sensitivity and specificity of anti-Sa autoantibodies for rheumatoid arthritisW Hueber, W Hassfeld, J S Smolen, et al.
Arthritis Research|February 15, 2001
The stressed synoviumG Schett, M Tohidast-Akrad, G Steiner, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1993
Testosterone modulation of N-acetylation in mouse kidneyT N Smolen, J A Brewer, W W Weber
Southern Medical Journal|January 1, 1984
Health problems during the first year of life in infants born to adolescent mothersP Smolen, C Miller, R O'Neal, et al.
Journal of Pharmaceutical Sciences|March 1, 1972
Relationship between dose, effect, time, and biophasic drug levelsV F Smolen, R G Barile, T G Theophanous
Annals of the New York Academy of Sciences|August 30, 2005
Pathogenesis of rheumatoid arthritis: targeting cytokinesJochen Zwerina, Kurt Redlich, Georg Schett, et al.
Frontiers in Pediatrics|December 16, 2020
Vaccine Interactions With the Infant Microbiome: Do They Define Health and Disease?Candice E Ruck, Oludare A Odumade, Kinga K Smolen
Clinical and Experimental Rheumatology|October 17, 2013
Possible discontinuation of therapies in inflammatory rheumatic diseases - as with initiation of therapies, a shared decision between patient and rheumatologistTheodore Pincus, Juergen Braun, Arthur Kavanaugh, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 11, 1975
Bioavailability analysis of chlorpromazine in humans from pupilometric dataV F Smolen, H R Murdock, E J Williams
Pageof 173

Showing results (421-430 of 1,726) with videos related to

Sort By:
Pageof 173
Journal of Pharmaceutical Sciences|May 1, 1970
Controlled drug release through polymeric filmsA L Fites, G S Banker, V F Smolen
Rheumatology (Oxford, England)|May 26, 1999
Sensitivity and specificity of anti-Sa autoantibodies for rheumatoid arthritisW Hueber, W Hassfeld, J S Smolen, et al.
Arthritis Research|February 15, 2001
The stressed synoviumG Schett, M Tohidast-Akrad, G Steiner, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1993
Testosterone modulation of N-acetylation in mouse kidneyT N Smolen, J A Brewer, W W Weber
Southern Medical Journal|January 1, 1984
Health problems during the first year of life in infants born to adolescent mothersP Smolen, C Miller, R O'Neal, et al.
Journal of Pharmaceutical Sciences|March 1, 1972
Relationship between dose, effect, time, and biophasic drug levelsV F Smolen, R G Barile, T G Theophanous
Annals of the New York Academy of Sciences|August 30, 2005
Pathogenesis of rheumatoid arthritis: targeting cytokinesJochen Zwerina, Kurt Redlich, Georg Schett, et al.
Frontiers in Pediatrics|December 16, 2020
Vaccine Interactions With the Infant Microbiome: Do They Define Health and Disease?Candice E Ruck, Oludare A Odumade, Kinga K Smolen
Clinical and Experimental Rheumatology|October 17, 2013
Possible discontinuation of therapies in inflammatory rheumatic diseases - as with initiation of therapies, a shared decision between patient and rheumatologistTheodore Pincus, Juergen Braun, Arthur Kavanaugh, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 11, 1975
Bioavailability analysis of chlorpromazine in humans from pupilometric dataV F Smolen, H R Murdock, E J Williams
Pageof 173